Plus Therapeutics, Inc. (PSTV)
USD 1.0
(-6.54%)
USD 1.0
(-6.54%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 4.91 Million | 224 Thousand | - | 303 Thousand | 6.99 Million | 2.98 Million |
| Cost of Revenue | 9.69 Million | 712 Thousand | 66 Thousand | 2.7 Million | 5.36 Million | 1.14 Million |
| Gross Profit | -4.77 Million | -488 Thousand | -66 Thousand | -2.39 Million | 1.63 Million | 1.83 Million |
| Operating Expenses | 8.54 Million | 19.93 Million | 12.42 Million | 9.88 Million | 10.65 Million | 11.74 Million |
| Selling, General and Administrative Expenses | 8.54 Million | 10.23 Million | 6.85 Million | 6.4 Million | 5.29 Million | 6.22 Million |
| Research and Development Expenses | 9.69 Million | 9.69 Million | 5.57 Million | 3.48 Million | 5.36 Million | 5.52 Million |
| Other Expenses | -9.69 Million | 1000.00 | 6000.00 | 781 Thousand | -1.23 Million | -470 Thousand |
| Cost and Expenses | 18.23 Million | 19.93 Million | 12.42 Million | 9.88 Million | 10.65 Million | 11.74 Million |
| Operating Income | -13.32 Million | -19.71 Million | -12.49 Million | -9.58 Million | -3.65 Million | -8.76 Million |
| Interest Expense | 395 Thousand | 711 Thousand | 932 Thousand | 1.1 Million | 1.85 Million | 1.92 Million |
| Income Tax Expense | - | 563 Thousand | 932 Thousand | 1.1 Million | 9.45 Million | 1.98 Million |
| Earnings before Tax | -13.31 Million | -20.27 Million | -13.39 Million | -8.24 Million | -3.28 Million | -8.87 Million |
| Net Income | -13.31 Million | -20.83 Million | -14.33 Million | -9.34 Million | -12.74 Million | -12.63 Million |
| Earnings Per Share Basic | -4.24 | -11.91 | -17.78 | -31.67 | -138.10 | -1090.08 |
| Earnings Per Share Diluted | -4.24 | -11.91 | -17.78 | -31.67 | -138.10 | -1090.08 |
| Weighted Average Shares Outstanding | 3.14 Million | 1.75 Million | 805.94 Thousand | 295.18 Thousand | 92.26 Thousand | 11.59 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 3.14 Million | 1.75 Million | 805.94 Thousand | 295.18 Thousand | 92.26 Thousand | 11.59 Thousand |
| Gross Margin | -0.97 | -2.18 | - | -7.91 | 0.23 | 0.62 |
| EBIT Margin | -2.58 | -84.58 | - | -30.26 | -0.39 | -2.25 |
| Profit Margin | -2.71 | -93.03 | - | -30.85 | -1.82 | -4.24 |
| EBITDA | -12.69 Million | -18.85 Million | -12.49 Million | -6.76 Million | -987 Thousand | -6.57 Million |
| Earnings Before Tax Margin | -2.71 | -88.00 | - | -31.63 | -0.52 | -2.94 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.27 Million | 1.67 Million | 1.31 Million | 4.91 Million | 1.24 Million | 1.85 Million |
| Cost of Revenue | 202 Thousand | 186 Thousand | 182 Thousand | 745 Thousand | 188 Thousand | 188 Thousand |
| Gross Profit | 1.07 Million | 1.49 Million | 1.13 Million | 4.16 Million | 1.05 Million | 1.66 Million |
| Operating Expenses | 4.77 Million | 4.79 Million | 4.99 Million | 17.48 Million | 3.25 Million | 3.34 Million |
| Selling, General and Administrative Expenses | 2 Million | 2.02 Million | 2.19 Million | - | 1.99 Million | 1.92 Million |
| Research and Development Expenses | 2.77 Million | 2.76 Million | 2.79 Million | - | 2.49 Million | 1.42 Million |
| Other Expenses | -2.77 Million | - | - | - | - | - |
| Cost and Expenses | 4.97 Million | 4.97 Million | 5.17 Million | 18.23 Million | 3.25 Million | 3.34 Million |
| Operating Income | -3.69 Million | -3.29 Million | -3.86 Million | -13.32 Million | -3.25 Million | -1.49 Million |
| Interest Expense | 3.57 Million | 34 Thousand | 62 Thousand | 395 Thousand | 87 Thousand | 112 Thousand |
| Income Tax Expense | - | 142.72 Thousand | 138.18 Thousand | - | 119 Thousand | 120 Thousand |
| Earnings before Tax | -2.94 Million | -3.26 Million | -3.81 Million | -13.31 Million | -3.21 Million | -1.48 Million |
| Net Income | -2.94 Million | -3.26 Million | -3.81 Million | -13.31 Million | -3.21 Million | -1.48 Million |
| Earnings Per Share Basic | -0.45 | -0.75 | -0.84 | - | -1.00 | -0.59 |
| Earnings Per Share Diluted | -0.27 | -0.75 | -0.84 | - | -1.00 | -0.59 |
| Weighted Average Shares Outstanding | 6.5 Million | 4.32 Million | 4.52 Million | 3.14 Million | 3.22 Million | 2.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 10.74 Million | 4.32 Million | 4.52 Million | 3.14 Million | 3.22 Million | 2.5 Million |
| Gross Margin | 0.84 | 0.89 | 0.86 | 0.85 | 0.85 | 0.90 |
| EBIT Margin | -2.73 | -1.86 | -2.80 | - | -2.33 | -0.67 |
| Profit Margin | -2.30 | -1.94 | -2.90 | -2.71 | -2.60 | -0.80 |
| EBITDA | -3.49 Million | -3.11 Million | -3.67 Million | - | -2.88 Million | -1.23 Million |
| Earnings Before Tax Margin | -2.89 | -1.97 | -2.94 | -2.71 | -2.62 | -0.80 |
C-PN
CG
NXLLF
YPSN
DYNAVSN
AM7